ANAC

Anacor Pharmaceuticals, Inc. News Headlines

$24.78
*  
0.01
0.04%
Get ANAC Alerts
*Delayed - data as of Sep. 16, 2014  -  Find a broker to begin trading ANAC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog
9/16/2014 4:14:00 PM - Zacks.com

Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog
9/15/2014 3:42:00 PM - Zacks.com

Tuesday 9/9 Insider Buying Report: CMRX, ANAC
9/9/2014 12:09:15 PM - BNK Invest

InsiderInsights.com Daily Round Up 9/8/14: Nuverra Environmental Solutions, Tableau Software, Conn's, OPKO Health
9/9/2014 9:43:00 AM - Seeking Alpha

Astellas' Antifungal Under FDA Review, Response by Mar 2015 - Analyst Blog
9/8/2014 5:50:00 PM - Zacks.com

Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog
8/15/2014 9:00:00 AM - Zacks.com

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog
8/14/2014 3:30:00 PM - Zacks.com

Anacor Pharma To Present At Canaccord Genuity Conference; Webcast At 3:30 PM ET
8/14/2014 2:30:00 PM - RTT News

Anacor (ANAC) Shares March Higher, Can It Continue? - Tale of the Tape
8/13/2014 9:49:19 AM - Zacks.com

Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
8/13/2014 9:10:00 AM - Zacks.com

Anacor Pharma To Present At Wedbush Life Conference; Webcast At 8:35 AM ET
8/13/2014 7:35:00 AM - RTT News

Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog
8/12/2014 10:50:00 AM - Zacks.com

Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus - Analyst Blog
8/12/2014 9:58:00 AM - Zacks.com

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog
8/12/2014 9:20:00 AM - Zacks.com

ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog
8/11/2014 12:21:00 PM - Zacks.com

Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog
8/11/2014 11:50:00 AM - Zacks.com

Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
8/6/2014 5:45:00 PM - Zacks.com

Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog
8/6/2014 5:00:00 PM - Zacks.com

Should You Buy Anacor Pharmaceuticals (ANAC) Ahead of Earnings? - Tale of the Tape
8/6/2014 8:48:30 AM - Zacks.com

Is Tenet Healthcare (THC) Poised to Beat Earnings in Q2? - Analyst Blog
8/1/2014 4:55:00 PM - Zacks.com

Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. - Analyst Blog
7/22/2014 5:05:00 PM - Zacks.com

Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape
7/22/2014 8:44:00 AM - Zacks.com

ACT Gets FDA Date, CGIX Opens Wallet, DPRX Once Again Takes OneStep Forward
7/21/2014 11:06:00 PM - RTT News

Anacor's Kerydin Gets FDA Nod for Onychomycosis - Analyst Blog
7/9/2014 12:10:00 PM - Zacks.com

Notable Two Hundred Day Moving Average Cross - ANAC
7/8/2014 1:09:02 PM - BNK Invest